{"id":69561,"date":"2025-12-27T19:47:49","date_gmt":"2025-12-27T10:47:49","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/global-anesthesia-drugs-market-industry-mordor\/"},"modified":"2026-09-11T06:21:59","modified_gmt":"2026-09-10T21:21:59","slug":"global-anesthesia-drugs-market-industry-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/global-anesthesia-drugs-market-industry-mordor\/","title":{"rendered":"\u9ebb\u9154\u85ac\u5e02\u5834 \u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u30c8\u30ec\u30f3\u30c9\u3068\u898b\u901a\u3057 (2025-2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/global-anesthesia-drugs-market-industry_1661862084984_Picture4-scaled.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/global-anesthesia-drugs-market-industry-size-image-1735450984893.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u6761\u4ef6\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u306e\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u306e\u52d5\u5411<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u9ebb\u9154\u85ac\u306e\u65b0\u898f\u627f\u8a8d<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \u65b0\u898f\u958b\u767a\u85ac\u306e\u30b3\u30b9\u30c8\u524a\u6e1b<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u5236\u7d04<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u5168\u8eab\u9ebb\u9154\u85ac\u306e\u526f\u4f5c\u7528<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u719f\u7df4\u3057\u305f\u9ebb\u9154\u533b\u306e\u4e0d\u8db3<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.4.1 \u65b0\u898f\u53c2\u5165\u8005\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.2 \u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.4.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u30bb\u30b0\u30e1\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3 (\u91d1\u984d\u5225\u5e02\u5834\u898f\u6a21 &#8211; 100\u4e07\u7c73\u30c9\u30eb)<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u85ac\u5264\u30bf\u30a4\u30d7\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u5168\u8eab\u9ebb\u9154\u85ac<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.1 \u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.2 \u30bb\u30dc\u30d5\u30eb\u30e9\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.3 \u30c7\u30b9\u30d5\u30eb\u30e9\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.4 \u30c7\u30af\u30b9\u30e1\u30c7\u30c8\u30df\u30b8\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.5 \u30ec\u30df\u30d5\u30a7\u30f3\u30bf\u30cb\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.6 \u30df\u30c0\u30be\u30e9\u30e0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.1.7 \u305d\u306e\u4ed6\u306e\u5168\u8eab\u9ebb\u9154\u85ac<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u5c40\u6240\u9ebb\u9154\u85ac<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.1 \u30d6\u30d4\u30d0\u30ab\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.2 \u30ed\u30d4\u30d0\u30ab\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.3 \u30ea\u30c9\u30ab\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.4 \u30af\u30ed\u30ed\u30d7\u30ed\u30ab\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.5 \u30d7\u30ea\u30ed\u30ab\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.6 \u30d9\u30f3\u30be\u30ab\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.1.2.7 \u305d\u306e\u4ed6\u306e\u5c40\u6240\u9ebb\u9154\u85ac<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u6295\u4e0e\u7d4c\u8def\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u5438\u5165<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u6ce8\u5c04<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.3 \u305d\u306e\u4ed6\u306e\u6295\u4e0e\u7d4c\u8def<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u7528\u9014\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u4e00\u822c\u5916\u79d1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u5f62\u6210\u5916\u79d1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u7f8e\u5bb9\u5916\u79d1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.4 \u6b6f\u79d1\u624b\u8853<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.5 \u305d\u306e\u4ed6\u306e\u7528\u9014<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.2 \u82f1\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.4.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u4f01\u696d\u6982\u8981<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.1.1 AbbVie Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.2 Apsen Pharmacare Holdings Limited<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.3 Baxter International Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.4 B. Braun Melsungen AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.5 Fresenius SE &amp; Co. KGaA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.6 Pfizer Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.7 Teva Pharmaceutical Industries Limited<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.8 Dr. Reddy&#8217;s Laboratories<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.9 Abbott Laboratories Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.10 Novartis AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.1.11 Eisai Inc.<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\u30ea\u30b9\u30c8\u306f\u7db2\u7f85\u7684\u3067\u306f\u3042\u308a\u307e\u305b\u3093 <\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9<\/p>\n<div style=\"font-family: regular_semibold;\">\u5165\u624b\u53ef\u80fd\u6027\u306b\u3088\u308b<\/div>\n<div style=\"font-family: regular_semibold;\">\n    \u7af6\u5408\u60c5\u52e2\u306e\u5bfe\u8c61 &#8211; \u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\n  <\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u9ebb\u9154\u85ac\u5e02\u5834\u30ec\u30dd\u30fc\u30c8\u306e\u6982\u8981\u3092\u65e5\u672c\u8a9e\u3067\u3054\u8aac\u660e\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u6982\u8981<\/p>\n<p>\u4e16\u754c\u306e\u9ebb\u9154\u85ac\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f75.1\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012030\u5e74\u306b\u306f88.7\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e88\u6e2c\u671f\u9593\uff082025\u5e74\uff5e2030\u5e74\uff09\u306b\u304a\u3051\u308b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f3.4%\u3067\u3059\u3002\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3059\u308b\u5e02\u5834\u3067\u3042\u308a\u3001\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\uff08COVID-19\uff09\u306e\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u767a\u751f\u306b\u3088\u308a\u30012020\u5e74\u306b\u306f\u624b\u8853\u306e\u5ef6\u671f\u3084\u4e2d\u6b62\u304c\u767a\u751f\u3057\u3001\u9ebb\u9154\u85ac\u306e\u9700\u8981\u306f\u4e00\u6642\u7684\u306b\u6e1b\u5c11\u3057\u307e\u3057\u305f\u30022020\u5e745\u6708\u306bBritish Journal of Surgery\u306b\u63b2\u8f09\u3055\u308c\u305f\u7814\u7a76\u306b\u3088\u308b\u3068\u3001COVID-19\u306b\u3088\u308b\u75c5\u9662\u30b5\u30fc\u30d3\u30b9\u3078\u306e\u5f71\u97ff\u304c\u30d4\u30fc\u30af\u306b\u9054\u3057\u305f12\u9031\u9593\u3067\u3001\u4e16\u754c\u4e2d\u3067\u7d042,840\u4e07\u4ef6\u306e\u9078\u629e\u7684\u624b\u8853\u304c\u4e2d\u6b62\u307e\u305f\u306f\u5ef6\u671f\u3055\u308c\u305f\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u6d3b\u52d5\u304c\u518d\u958b\u3055\u308c\u308b\u306b\u3064\u308c\u3066\u3001\u5ef6\u671f\u3055\u308c\u3066\u3044\u305f\u624b\u8853\u304c\u5b8c\u4e86\u3055\u308c\u3001\u9ebb\u9154\u85ac\u306e\u6d88\u8cbb\u91cf\u304c\u5897\u52a0\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u5e02\u5834\u6210\u9577\u306e\u4e3b\u306a\u63a8\u9032\u8981\u56e0\u306f\u3001\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u3068\u65b0\u3057\u3044\u9ebb\u9154\u85ac\u306e\u627f\u8a8d\u3067\u3059\u3002\u7c73\u56fd\u5f62\u6210\u5916\u79d1\u5b66\u4f1a\u306b\u3088\u308b\u3068\u30012020\u5e74\u306b\u306f\u7c73\u56fd\u3067230\u4e07\u4ef6\u306e\u7f8e\u5bb9\u5916\u79d1\u624b\u8853\u30011,320\u4e07\u4ef6\u306e\u4f4e\u4fb5\u8972\u7f8e\u5bb9\u51e6\u7f6e\u3001680\u4e07\u4ef6\u306e\u518d\u5efa\u624b\u8853\u304c\u884c\u308f\u308c\u3001\u3053\u308c\u306f2019\u5e74\u3068\u6bd4\u8f03\u3057\u30663%\u306e\u5897\u52a0\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u3092\u793a\u3057\u3066\u304a\u308a\u3001\u7d50\u679c\u3068\u3057\u3066\u9ebb\u9154\u85ac\u306e\u9700\u8981\u3092\u9ad8\u3081\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u30012020\u5e747\u6708\u306bNational Center for Biotechnology Information\uff08NCBI\uff09\u306b\u63b2\u8f09\u3055\u308c\u305f\u8a18\u4e8b\u300cTrauma of Major Surgery\u300d\u306b\u3088\u308b\u3068\u3001\u4e16\u754c\u4e2d\u3067\u5e74\u95933\u51041,000\u4e07\u4ef6\u3082\u306e\u5927\u898f\u6a21\u624b\u8853\u304c\u884c\u308f\u308c\u3066\u3044\u307e\u3059\u3002\u540c\u69d8\u306b\u30012021\u5e747\u6708\u306b\u767a\u8868\u3055\u308c\u305f\u8a18\u4e8b\u300cIncidence and Cumulative Risk of Major Surgery in Older Persons in the United States\u300d\u3067\u306f\u3001\u7c73\u56fd\u3067\u306f\u9ad8\u9f62\u8005100\u4eba\u3042\u305f\u308a\u5e74\u9593\u7d049\u4ef6\u306e\u5927\u898f\u6a21\u624b\u8853\u304c\u884c\u308f\u308c\u30015\u5e74\u9593\u30677\u4eba\u306b1\u4eba\u4ee5\u4e0a\u306e\u30e1\u30c7\u30a3\u30b1\u30a2\u53d7\u7d66\u8005\u304c\u5927\u898f\u6a21\u624b\u8853\u3092\u53d7\u3051\u3066\u304a\u308a\u3001\u3053\u308c\u306f\u7d04500\u4e07\u4eba\u306e\u9ad8\u9f62\u8005\u306b\u76f8\u5f53\u3059\u308b\u3068\u5831\u544a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u307e\u305f\u3001\u65b0\u3057\u3044\u5c40\u6240\u9ebb\u9154\u85ac\u306e\u958b\u767a\u3068\u627f\u8a8d\u306f\u3001\u5e02\u5834\u53c2\u52a0\u8005\u306b\u3068\u3063\u3066\u65b0\u305f\u306a\u53ce\u76ca\u6e90\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012021\u5e742\u6708\u306b\u306fPainPass\u304c\u6162\u6027\u75bc\u75db\u304a\u3088\u3073\u5916\u90e8\u7b4b\u8089\u306e\u9ebb\u75fa\u3092\u5bfe\u8c61\u3068\u3057\u305f\u521d\u306e\u30ab\u30f3\u30ca\u30d3\u30b8\u30aa\u30fc\u30eb\uff08CBD\uff09\/\u30ea\u30c9\u30ab\u30a4\u30f3\u88fd\u54c1\u30e9\u30a4\u30f3\u3092\u767a\u58f2\u3057\u3001\u5c40\u6240\u9ebb\u9154\u85ac\u5e02\u5834\u306e\u6210\u9577\u306b\u8ca2\u732e\u3057\u307e\u3057\u305f\u30022021\u5e7412\u6708\u306b\u306f\u3001Hikma Pharmaceuticals PLC\uff08Hikma\uff09\u304c\u7c73\u56fd\u5b50\u4f1a\u793e\u3092\u901a\u3058\u3066\u30d6\u30d4\u30d0\u30ab\u30a4\u30f3\u5869\u9178\u5869\u6ce8\u5c04\u6db2USP\uff080.25%\u30010.5%\u30010.75%\u306e10mL\u304a\u3088\u307330mL\u7528\u91cf\uff09\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u3055\u3089\u306b\u30012021\u5e746\u6708\u306b\u306fPAION AG\u304c\u3001\u6210\u4eba\u306b\u304a\u3051\u308b\u51e6\u7f6e\u93ae\u9759\u85ac\u3068\u3057\u3066Byfavo\uff08\u30ec\u30df\u30de\u30be\u30e9\u30e0\u30d9\u30b7\u30ec\u30fc\u30c8\uff09\u306e\u82f1\u56fd\u533b\u85ac\u54c1\u533b\u7642\u88fd\u54c1\u898f\u5236\u5e81\uff08MHRA\uff09\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u8981\u56e0\u3001\u3059\u306a\u308f\u3061\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u3068\u88fd\u54c1\u767a\u58f2\u304c\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e02\u5834\u3092\u727d\u5f15\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf<\/p>\n<p>\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u30bb\u30b0\u30e1\u30f3\u30c8\u306f\u5168\u8eab\u9ebb\u9154\u85ac\u30bb\u30b0\u30e1\u30f3\u30c8\u3067\u6700\u3082\u6025\u901f\u306a\u6210\u9577\u3092\u793a\u3059\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u306f\u624b\u8853\u3067\u6700\u3082\u4e00\u822c\u7684\u306b\u4f7f\u7528\u3055\u308c\u308b\u5168\u8eab\u9ebb\u9154\u85ac\u306e\u4e00\u3064\u3067\u3042\u308a\u3001\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u5e02\u5834\u306e\u4e3b\u8981\u306a\u69cb\u6210\u8981\u7d20\u3067\u3059\u3002\u96c6\u4e2d\u6cbb\u7642\u5ba4\uff08ICU\uff09\u3067\u306e\u91cd\u75c7\u60a3\u8005\uff08COVID-19\u60a3\u8005\u3092\u542b\u3080\uff09\u306e\u93ae\u9759\u3001\u51e6\u7f6e\u93ae\u9759\u3001\u5168\u8eab\u9ebb\u9154\u306e\u5c0e\u5165\u304a\u3088\u3073\u7dad\u6301\u306a\u3069\u306b\u4f7f\u7528\u3055\u308c\u307e\u3059\u30022020\u5e746\u6708\u306b\u306f\u3001\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u304c\u3001\u6a5f\u68b0\u63db\u6c17\u3092\u5fc5\u8981\u3068\u3059\u308bCOVID-19\u60a3\u8005\uff0816\u6b73\u4ee5\u4e0a\uff09\u306e\u93ae\u9759\u7dad\u6301\u306e\u305f\u3081\u306b\u3001\u30d5\u30ec\u30bc\u30cb\u30a6\u30b9\u30fb\u30d7\u30ed\u30dd\u30d9\u30f32%\u30a8\u30de\u30eb\u30b8\u30e7\u30f3\u306e\u4f7f\u7528\u3092\u627f\u8a8d\u3057\u307e\u3057\u305f\u3002\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u306f\u3001\u9ebb\u9154\u306e\u5c0e\u5165\u3068\u7dad\u6301\u3001\u304a\u3088\u3073\u96e3\u6cbb\u6027\u3066\u3093\u304b\u3093\u91cd\u7a4d\u72b6\u614b\u306e\u7ba1\u7406\u306b\u3082\u4f7f\u7528\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u88fd\u9020\u4f01\u696d\u306b\u306f\u3001Neon Laboratories Limited\u3001Bharat Serums and Vaccines Limited\u3001Fresenius Kabi\u306a\u3069\u304c\u3042\u308a\u307e\u3059\u30022021\u5e745\u6708\u306bBritish Journal of Anesthesiology\u306b\u63b2\u8f09\u3055\u308c\u305f\u7814\u7a76\u300cSurgical activity in England and Wales during the COVID-19 pandemic: a nationwide observational cohort study\u300d\u306b\u3088\u308b\u3068\u30012020\u5e74\u306b\u30a4\u30f3\u30b0\u30e9\u30f3\u30c9\u3068\u30a6\u30a7\u30fc\u30eb\u30ba\u3067\u884c\u308f\u308c\u305f\u624b\u8853\u306e\u7dcf\u6570\u306f3,102,674\u4ef6\u3067\u3057\u305f\u3002\u3057\u305f\u304c\u3063\u3066\u3001\u7dca\u6025\u624b\u8853\u306e\u5897\u52a0\u3001\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u306e\u5e83\u7bc4\u306a\u4f7f\u7528\u3001\u305d\u306e\u77ed\u6642\u9593\u4f5c\u7528\u7279\u6027\u3001\u304a\u3088\u3073\u4e16\u754c\u7684\u306a\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u304c\u3001\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u5e02\u5834\u306e\u6210\u9577\u3092\u63a8\u9032\u3059\u308b\u4e3b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8981\u56e0\u306b\u3088\u308a\u3001\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u6ce8\u5c04\u85ac\u5e02\u5834\u306f\u4e88\u6e2c\u671f\u9593\u4e2d\u306b\u5065\u5168\u306a\u6210\u9577\u3092\u7d4c\u9a13\u3057\u3001\u5168\u8eab\u9ebb\u9154\u85ac\u5e02\u5834\u306b\u826f\u3044\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u5317\u7c73\u304c\u5e02\u5834\u3092\u652f\u914d\u3057\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u3082\u305d\u306e\u50be\u5411\u304c\u7d9a\u304f\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n\u5317\u7c73\u306f\u73fe\u5728\u3001\u9ebb\u9154\u85ac\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u304a\u308a\u3001\u7279\u306b\u7c73\u56fd\u306e\u5168\u8eab\u9ebb\u9154\u85ac\u5e02\u5834\u306f\u4e16\u754c\u6700\u5927\u306e\u5730\u57df\u5e02\u5834\u3067\u3059\u3002COVID-19\u306e\u51fa\u73fe\u306b\u3088\u308a\u3001\u7c73\u56fd\u3067\u306f\u30c7\u30af\u30b9\u30e1\u30c7\u30c8\u30df\u30b8\u30f3\u3001\u30df\u30c0\u30be\u30e9\u30e0\u3001\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u3001\u795e\u7d4c\u7b4b\u906e\u65ad\u85ac\u306a\u3069\u306e\u91cd\u8981\u306a\u9ebb\u9154\u85ac\u304c\u6df1\u523b\u306a\u4e0d\u8db3\u306b\u76f4\u9762\u3057\u307e\u3057\u305f\u3002\u305d\u306e\u7d50\u679c\u3001\u591a\u304f\u306e\u4f01\u696d\u304c\u9ebb\u9154\u85ac\u306e\u751f\u7523\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012020\u5e745\u6708\u306b\u306fHikma Pharmaceutical\u304c\u7c73\u56fd\u3067\u300c\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u6ce8\u5c04\u7528\u30a8\u30de\u30eb\u30b8\u30e7\u30f3\u300d\u3092\u5c0e\u5165\u3057\u307e\u3057\u305f\u3002\u3055\u3089\u306b\u3001\u3053\u306e\u5e02\u5834\u306f\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u3001\u6162\u6027\u75be\u60a3\u3092\u62b1\u3048\u308b\u9ad8\u9f62\u8005\u4eba\u53e3\u306e\u5897\u52a0\u3001\u9ebb\u9154\u6280\u8853\u306e\u9032\u6b69\u306b\u3088\u3063\u3066\u727d\u5f15\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u7c73\u56fd\u5f62\u6210\u5916\u79d1\u5b66\u4f1a\uff08ASPS\uff09\u306b\u3088\u308b\u3068\u30012020\u5e74\u306b\u306f10\uff5e29\u6b73\u306e\u4eba\u3005\u3067\u7d0476\u4e078,000\u4ef6\u306e\u7f8e\u5bb9\u51e6\u7f6e\u304c\u300140\uff5e54\u6b73\u306e\u4eba\u3005\u3067\u306f610\u4e07\u4ef6\u306e\u7f8e\u5bb9\u51e6\u7f6e\u304c\u884c\u308f\u308c\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306e\u7d71\u8a08\u306f\u3001\u3053\u306e\u5730\u57df\u3067\u624b\u8853\u4ef6\u6570\u304c\u7d76\u3048\u305a\u5897\u52a0\u3057\u3066\u304a\u308a\u3001\u6700\u7d42\u7684\u306b\u9ebb\u9154\u85ac\u306e\u9700\u8981\u3092\u4fc3\u9032\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u822c\u5916\u79d1\u306b\u304a\u3051\u308b\u9ebb\u9154\u85ac\u306e\u9069\u7528\u306f\u3001\u5e02\u5834\u306e\u6210\u9577\u306b\u5927\u304d\u304f\u8ca2\u732e\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u56fd\u5185\u3067\u306f\u65b0\u3057\u3044\u9ebb\u9154\u85ac\u304c\u958b\u767a\u3055\u308c\u3066\u304a\u308a\u3001\u5e02\u5834\u306e\u6210\u9577\u3092\u4fc3\u9032\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002\u4f8b\u3048\u3070\u30012020\u5e746\u6708\u306b\u306fMedova\u3068New York School of Regional Anesthesia\uff08NYSORA\uff09\u304c\u3001\u7c73\u56fd\u3067SAFIRA\uff08SAFer Injection for Regional Anesthesia\uff09\u3092\u5c0e\u5165\u3059\u308b\u305f\u3081\u306e\u63d0\u643a\u3092\u7d50\u3073\u307e\u3057\u305f\u30022020\u5e741\u6708\u306b\u306f\u3001\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u304cLannett Company\u88fd\u306e\u30b3\u30ab\u30a4\u30f3\u5869\u9178\u5869\uff08HCI; NUMBRINO\uff09\u9f3b\u8154\u7528\u6eb6\u6db24%\uff0840 mg\/mL\uff09\u306e\u9ebb\u9154\u85ac\u3068\u3057\u3066\u306e\u65b0\u85ac\u7533\u8acb\u3092\u627f\u8a8d\u3057\u307e\u3057\u305f\u30022021\u5e7412\u6708\u306b\u306f\u3001Hikma Pharmaceuticals PLC\uff08Hikma\uff09\u304c\u7c73\u56fd\u5b50\u4f1a\u793e\u3092\u901a\u3058\u3066\u30d6\u30d4\u30d0\u30ab\u30a4\u30f3\u5869\u9178\u5869\u6ce8\u5c04\u6db2USP\u3092\u767a\u58f2\u3057\u307e\u3057\u305f\u3002\u540c\u69d8\u306b\u30012020\u5e744\u6708\u306b\u306fBlue-Zone Technologies Ltd\u304c\u3001\u5168\u8eab\u9ebb\u9154\u306b\u4f7f\u7528\u3055\u308c\u308b\u9ebb\u9154\u85ac\u3067\u3042\u308b\u30c7\u30b9\u30d5\u30eb\u30e9\u30f3USP\u306b\u3064\u3044\u3066\u30ab\u30ca\u30c0\u4fdd\u5065\u7701\u306e\u627f\u8a8d\u3092\u5f97\u307e\u3057\u305f\u3002\u3053\u306e\u3088\u3046\u306a\u958b\u767a\u3068\u9ebb\u9154\u85ac\u3092\u4f7f\u7528\u3059\u308b\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u304c\u3001\u7279\u306b\u7c73\u56fd\u9ebb\u9154\u85ac\u5e02\u5834\u306b\u304a\u3044\u3066\u3001\u3053\u306e\u5730\u57df\u306e\u5e02\u5834\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<\/p>\n<p>\u9ebb\u9154\u85ac\u5e02\u5834\u306f\u7af6\u4e89\u304c\u6fc0\u3057\u304f\u3001\u3044\u304f\u3064\u304b\u306e\u4e3b\u8981\u306a\u30d7\u30ec\u30fc\u30e4\u30fc\u3067\u69cb\u6210\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u30b7\u30a7\u30a2\u306e\u89b3\u70b9\u304b\u3089\u306f\u3001\u5c11\u6570\u306e\u4e3b\u8981\u30d7\u30ec\u30fc\u30e4\u30fc\u304c\u73fe\u5728\u5e02\u5834\u3092\u652f\u914d\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u533b\u85ac\u54c1\u627f\u8a8d\u306e\u5897\u52a0\u306b\u4f34\u3044\u3001\u4e2d\u5805\u30fb\u4e2d\u5c0f\u4f01\u696d\u306f\u3088\u308a\u4f4e\u4fa1\u683c\u3067\u65b0\u3057\u3044\u6210\u5206\u3092\u5c0e\u5165\u3059\u308b\u3053\u3068\u3067\u5e02\u5834\u3067\u306e\u5b58\u5728\u611f\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002Baxter\u3001Abbott Laboratories\u3001Aspen\u3001Fresenius SE\u3001Roche\u3001B. Braun Melsungen AG\u306a\u3069\u306e\u4f01\u696d\u304c\u3001\u9ebb\u9154\u85ac\u5e02\u5834\u3067\u304b\u306a\u308a\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u4e3b\u8981\u306a\u9ebb\u9154\u85ac\u30e1\u30fc\u30ab\u30fc\u3067\u3059\u3002<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2022\u5e741\u6708\u3001Laboratoires Th\u00e9a SAS\uff08Th\u00e9a\uff09\u306fAkorn Operating Company LLC\u304b\u30897\u3064\u306e\u30d6\u30e9\u30f3\u30c9\u773c\u79d1\u88fd\u54c1\u3092\u8cfc\u5165\u3059\u308b\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u6226\u7565\u7684\u306a\u52d5\u304d\u306b\u3088\u308a\u3001Th\u00e9a\u306f\u773c\u79d1\u624b\u8853\u4e2d\u306e\u773c\u8868\u9762\u9ebb\u9154\u306b\u7528\u3044\u3089\u308c\u308b\u5c40\u6240\u9ebb\u9154\u85ac\u3067\u3042\u308bAkten\uff08\u30ea\u30c9\u30ab\u30a4\u30f3\u5869\u9178\u5869\u70b9\u773c\u30b2\u30eb\uff09\u3092\u542b\u3080Akorn\u30d6\u30e9\u30f3\u30c9\u88fd\u54c1\u3092\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306b\u8ffd\u52a0\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002<br \/>\n*   2022\u5e742\u6708\u3001Sedana Medical AB\u306f\u30c9\u30a4\u30c4\u3067Sedaconda\uff08\u30a4\u30bd\u30d5\u30eb\u30e9\u30f3\uff09\u306e\u767a\u58f2\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002Sedaconda\uff08\u30a4\u30bd\u30d5\u30eb\u30e9\u30f3\uff09\u306f2021\u5e747\u6708\u306b\u6b27\u5ddeDCP\u627f\u8a8d\u3092\u53d7\u3051\u3001\u3059\u3067\u306b14\u30ab\u56fd\u3067\u56fd\u5185\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u5e74\u306b\u306f\u8ffd\u52a0\u306e\u8ca9\u58f2\u627f\u8a8d\u7533\u8acb\u304c\u63d0\u51fa\u3055\u308c\u3066\u304a\u308a\u30012022\u5e74\u306b\u306f\u30a4\u30bf\u30ea\u30a2\u3001\u30dd\u30fc\u30e9\u30f3\u30c9\u3001\u30b9\u30a4\u30b9\u3001\u82f1\u56fd\u3067\u56fd\u5185\u627f\u8a8d\u3092\u53d7\u3051\u308b\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u9ebb\u9154\u85ac\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u9ebb\u9154\u85ac\u306f\u3001\u624b\u8853\u306b\u304a\u3044\u3066\u611f\u899a\u306e\u4e00\u6642\u7684\u306a\u55aa\u5931\u3092\u5f15\u304d\u8d77\u3053\u3059\u4e0d\u53ef\u6b20\u306a\u8981\u7d20\u3067\u3042\u308a\u3001\u4e2d\u67a2\u795e\u7d4c\u7cfb\u306e\u6d3b\u52d5\u3092\u6291\u5236\u3057\u5b8c\u5168\u306a\u7121\u611f\u899a\u72b6\u614b\u3092\u8a98\u767a\u3059\u308b\u5168\u8eab\u9ebb\u9154\u85ac\u3068\u3001\u7279\u5b9a\u306e\u90e8\u4f4d\u304b\u3089\u306e\u795e\u7d4c\u30a4\u30f3\u30d1\u30eb\u30b9\u4f1d\u9054\u3092\u5236\u9650\u3059\u308b\u5c40\u6240\u9ebb\u9154\u85ac\u306b\u5927\u5225\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u672c\u8abf\u67fb\u306f\u3001\u9ebb\u9154\u85ac\u5e02\u5834\u3092\u9ebb\u9154\u85ac\u306e\u7a2e\u985e\u3001\u6295\u4e0e\u7d4c\u8def\u3001\u7528\u9014\u3001\u304a\u3088\u3073\u5730\u57df\u5225\u306b\u8a73\u7d30\u306b\u5206\u6790\u3057\u3066\u3044\u307e\u3059\u3002\u9ebb\u9154\u85ac\u306e\u7a2e\u985e\u306f\u3001\u5168\u8eab\u9ebb\u9154\u85ac\u3068\u5c40\u6240\u9ebb\u9154\u85ac\u306b\u5206\u985e\u3055\u308c\u307e\u3059\u3002\u5168\u8eab\u9ebb\u9154\u85ac\u306b\u306f\u30d7\u30ed\u30dd\u30d5\u30a9\u30fc\u30eb\u3001\u30bb\u30dc\u30d5\u30eb\u30e9\u30f3\u3001\u30c7\u30b9\u30d5\u30eb\u30e9\u30f3\u3001\u30c7\u30af\u30b9\u30e1\u30c7\u30c8\u30df\u30b8\u30f3\u3001\u30ec\u30df\u30d5\u30a7\u30f3\u30bf\u30cb\u30eb\u3001\u30df\u30c0\u30be\u30e9\u30e0\u306a\u3069\u304c\u3001\u5c40\u6240\u9ebb\u9154\u85ac\u306b\u306f\u30d6\u30d4\u30d0\u30ab\u30a4\u30f3\u3001\u30ed\u30d4\u30d0\u30ab\u30a4\u30f3\u3001\u30ea\u30c9\u30ab\u30a4\u30f3\u3001\u30af\u30ed\u30ed\u30d7\u30ed\u30ab\u30a4\u30f3\u3001\u30d7\u30ea\u30ed\u30ab\u30a4\u30f3\u3001\u30d9\u30f3\u30be\u30ab\u30a4\u30f3\u306a\u3069\u304c\u4e3b\u8981\u306a\u85ac\u5264\u3068\u3057\u3066\u542b\u307e\u308c\u307e\u3059\u3002\u6295\u4e0e\u7d4c\u8def\u306f\u5438\u5165\u3001\u6ce8\u5c04\u3001\u305d\u306e\u4ed6\u306e\u7d4c\u8def\u306b\u5206\u985e\u3055\u308c\u3001\u7528\u9014\u306f\u4e00\u822c\u5916\u79d1\u3001\u5f62\u6210\u5916\u79d1\u3001\u7f8e\u5bb9\u5916\u79d1\u3001\u6b6f\u79d1\u5916\u79d1\u3001\u305d\u306e\u4ed6\u306e\u5916\u79d1\u624b\u8853\u304c\u5bfe\u8c61\u3067\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u5317\u7c73\uff08\u7c73\u56fd\u3001\u30ab\u30ca\u30c0\u3001\u30e1\u30ad\u30b7\u30b3\uff09\u3001\u6b27\u5dde\uff08\u30c9\u30a4\u30c4\u3001\u82f1\u56fd\u3001\u30d5\u30e9\u30f3\u30b9\u3001\u30a4\u30bf\u30ea\u30a2\u3001\u30b9\u30da\u30a4\u30f3\u306a\u3069\uff09\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\uff08\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u30a4\u30f3\u30c9\u3001\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u3001\u97d3\u56fd\u306a\u3069\uff09\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\uff08GCC\u3001\u5357\u30a2\u30d5\u30ea\u30ab\u306a\u3069\uff09\u3001\u5357\u7c73\uff08\u30d6\u30e9\u30b8\u30eb\u3001\u30a2\u30eb\u30bc\u30f3\u30c1\u30f3\u306a\u3069\uff09\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3066\u304a\u308a\u3001\u4e16\u754c\u306e\u4e3b\u8981\u5730\u57df\u306b\u304a\u3051\u308b17\u30ab\u56fd\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u304c\u7db2\u7f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5404\u30bb\u30b0\u30e1\u30f3\u30c8\u306e\u5e02\u5834\u898f\u6a21\u306f\u7c73\u30c9\u30eb\uff08USD million\uff09\u3067\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u306a\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u624b\u8853\u4ef6\u6570\u306e\u5897\u52a0\u3001\u65b0\u305f\u306a\u9ebb\u9154\u85ac\u306e\u627f\u8a8d\u3001\u304a\u3088\u3073\u65b0\u958b\u767a\u85ac\u306e\u30b3\u30b9\u30c8\u524a\u6e1b\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u4e00\u65b9\u3067\u3001\u5168\u8eab\u9ebb\u9154\u85ac\u306e\u526f\u4f5c\u7528\u3084\u719f\u7df4\u3057\u305f\u9ebb\u9154\u5c02\u9580\u533b\u306e\u4e0d\u8db3\u304c\u5e02\u5834\u306e\u6210\u9577\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u7af6\u4e89\u74b0\u5883\u3092\u5206\u6790\u3059\u308b\u305f\u3081\u3001\u30dd\u30fc\u30bf\u30fc\u306e\u30d5\u30a1\u30a4\u30d6\u30d5\u30a9\u30fc\u30b9\u5206\u6790\u3082\u5b9f\u65bd\u3055\u308c\u3066\u304a\u308a\u3001\u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01\u3001\u8cb7\u3044\u624b\/\u6d88\u8cbb\u8005\u306e\u4ea4\u6e09\u529b\u3001\u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b\u3001\u4ee3\u66ff\u54c1\u306e\u8105\u5a01\u3001\u7af6\u4e89\u306e\u6fc0\u3057\u3055\u3068\u3044\u3063\u305f\u5074\u9762\u304b\u3089\u5e02\u5834\u304c\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e16\u754c\u306e\u9ebb\u9154\u85ac\u5e02\u5834\u306f\u30012024\u5e74\u306b\u306f72.5\u5104\u7c73\u30c9\u30eb\u3068\u63a8\u5b9a\u3055\u308c\u30012025\u5e74\u306b\u306f75.1\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u5f8c\u30012025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff093.40%\u3067\u6210\u9577\u3057\u30012030\u5e74\u306b\u306f88.7\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u30012025\u5e74\u306b\u306f\u5317\u7c73\u304c\u6700\u5927\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u4e88\u6e2c\u671f\u9593\u4e2d\uff082025-2030\u5e74\uff09\u306b\u6700\u3082\u9ad8\u3044CAGR\u3067\u6210\u9577\u3059\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u30d7\u30ec\u30a4\u30e4\u30fc\u3068\u3057\u3066\u306f\u3001AbbVie Inc.\u3001Apsen Pharmacare Holdings Limited\u3001Baxter International Inc.\u3001B. Braun Melsungen AG\u3001Fresenius SE &#038; Co. KGaA\u3001Pfizer Inc.\u3001Teva Pharmaceutical Industries Limited\u3001Dr. Reddy&#8217;s Laboratories\u3001Abbott Laboratories Inc.\u3001Novartis AG\u3001Eisai Inc.\u306a\u3069\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u4f01\u696d\u306b\u3064\u3044\u3066\u306f\u3001\u4e8b\u696d\u6982\u8981\u3001\u8ca1\u52d9\u72b6\u6cc1\u3001\u88fd\u54c1\u3068\u6226\u7565\u3001\u6700\u8fd1\u306e\u52d5\u5411\u306a\u3069\u304c\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u30c8\u30ec\u30f3\u30c9\u306b\u3064\u3044\u3066\u3082\u8a00\u53ca\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/69561"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=69561"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/69561\/revisions"}],"predecessor-version":[{"id":69564,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/69561\/revisions\/69564"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=69561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=69561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=69561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}